Storia della carriera di Colin Meyer
Precedenti posizioni note di Colin Meyer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| REATA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 10/09/2013 | 07/02/2022 |
| Corporate Officer/Principal | 07/02/2022 | 26/09/2023 |
Formazione di Colin Meyer
| University of Virginia | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
| SMU-Cox School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
- Borsa valori
- Insiders
- Colin Meyer
- Esperienza
